• SNBL announces new effort to get Satsuma’s Atzumi DHE nasal powder for migraine into the US market

  More than a year after the FDA approved Satsuma’s Atzumi (STS 101) intranasal dry powder dihydroergotamine for the treatment of migraine in adults, Satsuma parent company SNBL says that it is still trying to find… [Read more . . .]

• Vertex ceases development of VX-522 inhaled RNA therapy for CF after stopping Phase 1/2 trial due to tolerability issues

  Vertex has stopped a Phase 1/2 study of VX-522 inhaled RNA therapy for the treatment of cystic fibrosis and has ceased development of the product, the company said in its most recent report of financial… [Read more . . .]

• Enterprise Therapeutics says Phase 2 trial of ETD001 inhaled ENaC blocker for CF met its primary endpoint

  Enterprise Therapeutics announced that a Phase 2 trial of ETD001, an inhaled epithelial sodium channel blocker, met its primary endpoint, demonstrating a statistically significant and clinically relevant improvement in lung function versus placebo after 28… [Read more . . .]

• Chance Pharma reports NMPA acceptance of NDA for CXG87 budesonide / formoterol DPI, Phase 3 results

  According to Chance Pharmaceuticals, China’s National Medical Products Administration has accepted the company’s NDA for CXG87 budesonide / formoterol DPI for the treatment of asthma. The announcement emphasizes that the formulation is Chance’s own “improved… [Read more . . .]

• Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

  CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing… [Read more . . .]

• Intertek announces expansion of GMP stability storage facility

• RDD 2026 exhibitor preview

• MannKind is developing ralinepag DPI (MNKD-1501) for United Therapeutics

• Merxin receives King’s Award for Enterprise, names new Head of Business Development

• Copley Scientific introduces new SRS 100i sample recovery system for inhaler testing

More news . . .